Angiodynamics (ANGO) Gross Margin (2010 - 2026)

Angiodynamics (ANGO) has reported Gross Margin for 17 consecutive years, with 54.01% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin rose 134.0% year-over-year to 54.01%; the trailing twelve-month figure through May 2026 stood at 54.62% (up 71.0% YoY), and the FY2026 full-year result was 54.62%, up 71.0% from the prior year.
• Gross Margin grew to 54.01% in Q2 2026 per ANGO's latest filing, from 52.89% in the prior quarter.
• Across five years, Gross Margin topped out at 56.38% in Q4 2025 and bottomed at 47.7% in Q1 2024.
• Historically, Gross Margin has averaged 52.75% across 5 years, with a median of 52.83% in 2022.
• The sharpest annual moves came in 2023 and 2025: Gross Margin tumbled 250 bps in 2023, then surged 627 bps in 2025.
• Over 5 years, Gross Margin stood at 52.77% in 2022, then slipped by 4 bps to 50.92% in 2023, then advanced by 8 bps to 54.78% in 2024, then increased by 3 bps to 56.38% in 2025, then decreased by 4 bps to 54.01% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 54.01%, 52.89%, and 56.38% for Q2 2026, Q1 2026, and Q4 2025 respectively.